Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

The reminder comes from St John Ambulance as warmer weather brings more outdoor activities and potential exposure to common ...

Cupra boss hints at hot hatch version of new five-door EV ...

Embecta Corp. ('embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings ...

Embecta Corp. ("embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced ...

ARS as a commercial company. It was a year focused on building infrastructure, educating the market and learning as we ...

An Oxfordshire-based medical device manufacturer has been acquired by a US-listed global counterpart specialising in diabetes ...

Cash Runway: As of March 31, 2026, ARS Pharma had cash, cash equivalents, and short-term investments of $201.0 million, with ...

U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive update ...

Good morning, and welcome to ARS Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I will now turn the ...